Cytophotometric DNA analysis of rectal mucosa of patients with ulcerative colitis

1985 ◽  
Vol 15 (4) ◽  
pp. 324-326 ◽  
Author(s):  
Hiroshi Suzuki ◽  
Shigeru Moriyama ◽  
Kazuaki Matsushima ◽  
Koichi Matsumoto ◽  
Keiji Iriyama
Keyword(s):  
Ulcerative Colitis ◽  
Dna Analysis ◽  
Rectal Mucosa ◽  
Cytophotometric Dna Analysis

Tissue CEA determination and cytophotometric DNA analysis of colorectal mucosa in patients with colorectal cancer

1985 ◽  
Vol 15 (6) ◽  
pp. 449-454 ◽  
Author(s):  
Hiroshi Suzuki ◽  
Eiichi Honda ◽  
Koichi Matsumoto ◽  
Keiji Iriyama
Keyword(s):  
Colorectal Cancer ◽  
Dna Analysis ◽  
Colorectal Mucosa ◽  
Cytophotometric Dna Analysis ◽  
Tissue Cea

The Role of Intestinal Microbes in Ulcerative Colitis: Studies on the Rectal Mucosa-Associated Microflora

1992 ◽  
pp. 125-127
Author(s):  
M. G. Hartley ◽  
M. J. Hudson ◽  
M. J. Hill ◽  
A. E. Gent ◽  
R. H. Grace ◽  
...  
Keyword(s):  
Ulcerative Colitis ◽  
Rectal Mucosa ◽  
Intestinal Microbes

Cytophotometric DNA Analysis of Superficial and Advanced Carcinoma of the Esophagus

1988 ◽  
pp. 31-34 ◽  
Author(s):  
K. Inokuchi ◽  
H. Kuwano ◽  
K. Sugimachi ◽  
Y. Koga ◽  
M. Kitamura ◽  
...  
Keyword(s):  
Dna Analysis ◽  
Carcinoma Of The Esophagus ◽  
Advanced Carcinoma ◽  
Cytophotometric Dna Analysis

Review of normal gastrointestinal tract, ulcerative colitis, proctitis and rectal medication adherence

2020 ◽  
Vol 29 (14) ◽  
pp. 805-811
Author(s):  
Pineshwari Naeck-Boolauky ◽  
Jitka Adio ◽  
Jennie Burch
Keyword(s):  
Ulcerative Colitis ◽  
Inflammatory Bowel Disease ◽  
Gastrointestinal Tract ◽  
Side Effects ◽  
Rectal Mucosa ◽  
Gi Tract ◽  
Therapeutic Outcomes ◽  
Rectal Medication ◽  
Inflammatory Bowel

The gastrointestinal (GI) tract has a number of functions—ingestion, digestion, absorption and elimination. When the GI tract is working normally, it is efficient. However, this can change when disease, such as inflammatory bowel disease (IBD) occurs. IBD is a long-term relapsing and remitting autoimmune disease; it incorporates ulcerative colitis (UC). In UC, part or all the mucosa lining the rectum and colon becomes inflamed and ulcerated. UC that affects the rectum only is called proctitis. Effective treatment is essential. It is better to target the rectal mucosa directly in proctitis, using topical rectal medications in enemas or suppositories, as these have fewer side-effects and resolve symptoms more quickly than systemic drugs. However, patients may not feel clear about aspects of their IBD care and can find it difficult to initiate and comply with treatment and maintenance regimens. Nurses need to educate and support them to achieve optimal therapeutic outcomes in both the immediate and long terms.

Substance P containing nerve fibers in rectal mucosa of ulcerative colitis

1997 ◽  
Vol 40 (6) ◽  
pp. 718-725 ◽  
Author(s):  
Toshiaki Watanabe ◽  
Yoshiro Kubota ◽  
Tetsuichiro Muto
Keyword(s):  
Ulcerative Colitis ◽  
Substance P ◽  
Rectal Mucosa ◽  
Nerve Fibers

scholarly journals Fish Oil in the Treatment of Ulcerative Colitis

1990 ◽  
Vol 4 (7) ◽  
pp. 420-423 ◽  
Author(s):  
C Ó'Moráin ◽  
A Tobin ◽  
T McColl ◽  
Y Suzuki
Keyword(s):  
Ulcerative Colitis ◽  
Arachidonic Acid ◽  
Mechanism Of Action ◽  
Mode Of Action ◽  
Rectal Mucosa ◽  
Leukotriene B4 ◽  
Biologically Active ◽  
Active Ulcerative Colitis ◽  
Pilot Studies ◽  
Lysosomal Membrane Stability

Patients with active ulcerative colitis have increased levels of leukotriene B4 in their rectal mucosa. Eicosapentaenoic acid (EPA) competitively inhibits the cyclo-oxgenase pathway and reduces the formation of cyclo-oxygenase pathway products. EPA is a good substrate for lipoxygenase enzymes and is efficiently converted to leukotriene 85, which is less biologically active. The conversion of EPA to leukotriene B5 is as efficient as that of arachidonic acid to teukotriene B4. Two pilot studies showed benefit of EPA in the treatment of ulcerative colitis. Two of three controlled studies suggest that EPA is more effective than placebo in the treatment of active chronic ulcerative colitis. The mechanism of action is probably reduction of leukotriene B4, but EPA could increase cell and lysosomal membrane stability, or it may exert its effect by reducing interleukin-l. More controlled studies and detailed investigation into the mode of action of EPA are required.

M2066 Evaluation of Global Gene Expression in Rectal Mucosa Obtained By a Non-Invasive Technique in Patients with Ulcerative Colitis

2008 ◽  
Vol 134 (4) ◽  
pp. A-462
Author(s):  
Yakov Gitin ◽  
Francis A. Farraye ◽  
Xiaoling Zhang ◽  
Gang Liu ◽  
Avrum Spira ◽  
...  
Keyword(s):  
Gene Expression ◽  
Ulcerative Colitis ◽  
Rectal Mucosa ◽  
Global Gene Expression ◽  
Invasive Technique ◽  
Non Invasive

scholarly journals Cytophotometric dna analysis of mucosal and submucosal carcinoma of the esophagus

Cancer ◽  
1984 ◽  
Vol 53 (12) ◽  
pp. 2683-2687 ◽  
Author(s):  
Keizo Sugimachi ◽  
Takeshi Okamura ◽  
Hiroshi Matsuura ◽  
Hiroko Ide ◽  
Mitsuo Endo ◽  
...  
Keyword(s):  
Dna Analysis ◽  
Carcinoma Of The Esophagus ◽  
Cytophotometric Dna Analysis
Sign in / Sign up

Export Citation Format

Share Document